Pullen Matthew F, Pastick Katelyn A, Williams Darlisha A, Nascene Alanna A, Bangdiwala Ananta S, Okafor Elizabeth C, Hullsiek Katherine Huppler, Skipper Caleb P, Lofgren Sarah M, Engen Nicole, Abassi Mahsa, McDonald Emily G, Lee Todd C, Rajasingham Radha, Boulware David R
Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA.
School of Public Health, University of Minnesota, Minneapolis, Minnesota, USA.
Open Forum Infect Dis. 2020 Dec 28;8(2):ofaa602. doi: 10.1093/ofid/ofaa602. eCollection 2021 Feb.
As the severe acute respiratory syndrome coronavirus 2 pandemic evolved, it was apparent that well designed and rapidly conducted randomized clinical trials were urgently needed. However, traditional clinical trial design presented several challenges. Notably, disease prevalence initially varied by time and region, and the pockets of outbreaks evolved geographically over time. Coupled with an occupational hazard from in-person study visits, timely recruitment would prove difficult in a traditional in-person clinical trial. Thus, our team opted to launch nationwide internet-based clinical trials using patient-reported outcome measures. In total, 2795 participants were recruited using traditional and social media, with screening and enrollment performed via an online data capture system. Follow-up surveys and survey reminders were similarly managed through this online system with manual participant outreach in the event of missing data. In this report, we present a narrative of our experience running internet-based clinical trials and provide recommendations for the design of future clinical trials during a world pandemic.
随着严重急性呼吸综合征冠状病毒2大流行的演变,很明显迫切需要精心设计并迅速开展的随机临床试验。然而,传统的临床试验设计面临着几个挑战。值得注意的是,疾病流行率最初随时间和地区而变化,疫情爆发区域也随时间在地理上发生演变。再加上亲自进行研究访问存在职业风险,在传统的亲自参与的临床试验中,及时招募患者将很困难。因此,我们的团队选择使用患者报告的结局指标开展全国性的基于互联网的临床试验。总共通过传统媒体和社交媒体招募了2795名参与者,通过在线数据采集系统进行筛选和入组。随访调查和调查提醒同样通过这个在线系统进行管理,在出现数据缺失的情况下会进行人工参与者外展。在本报告中,我们讲述了我们开展基于互联网的临床试验的经验,并为世界大流行期间未来临床试验的设计提供建议。